AI assistant
Sending…
RESMED INC — Director's Dealing 2026
Feb 6, 2026
30071_dirs_2026-02-06_a25bd9c6-50f8-49c4-a203-57cac24e8128.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2026-02-04
Reporting Person: Rider Michael J (Global General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-04 | ResMed Common Stock | S | 50 | $260.00 | Disposed | 9691 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 28, 2025.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 9